Jointown Pharmaceutical Group Co Ltd
SSE:600998

Watchlist Manager
Jointown Pharmaceutical Group Co Ltd Logo
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Watchlist
Price: 5.53 CNY -2.12% Market Closed
Market Cap: 27.9B CNY
Have any thoughts about
Jointown Pharmaceutical Group Co Ltd?
Write Note

Jointown Pharmaceutical Group Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jointown Pharmaceutical Group Co Ltd
Accounts Receivables Peer Comparison

Comparables:
1099
601607
C
600511
000963
Q
301015

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Accounts Receivables
ÂĄ35.1B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
19%
Sinopharm Group Co Ltd
HKEX:1099
Accounts Receivables
ÂĄ229.8B
CAGR 3-Years
8%
CAGR 5-Years
12%
CAGR 10-Years
15%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Accounts Receivables
ÂĄ72.9B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
13%
C
China National Medicines Corp Ltd
SSE:600511
Accounts Receivables
ÂĄ9.8B
CAGR 3-Years
17%
CAGR 5-Years
-1%
CAGR 10-Years
17%
Huadong Medicine Co Ltd
SZSE:000963
Accounts Receivables
ÂĄ8B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
10%
Q
Qingdao Baheal Medical Inc
SZSE:301015
Accounts Receivables
ÂĄ2.1B
CAGR 3-Years
10%
CAGR 5-Years
19%
CAGR 10-Years
N/A

See Also

What is Jointown Pharmaceutical Group Co Ltd's Accounts Receivables?
Accounts Receivables
35.1B CNY

Based on the financial report for Jun 30, 2024, Jointown Pharmaceutical Group Co Ltd's Accounts Receivables amounts to 35.1B CNY.

What is Jointown Pharmaceutical Group Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
19%

Over the last year, the Accounts Receivables growth was 5%. The average annual Accounts Receivables growth rates for Jointown Pharmaceutical Group Co Ltd have been 3% over the past three years , 6% over the past five years , and 19% over the past ten years .

Back to Top